pmed.1002894.g004.tif (1.3 MB)
Download fileAssembly of study cohorts that evaluate the impact of antiviral treatment on the risks for infectious diseases morbidity and mortality in HCV and HBV patients.
figure
posted on 2019-09-13, 17:28 authored by Yen-Chieh Lee, Jiun-Ling Wang, Yaa-Hui Dong, Hsi-Chieh Chen, Li-Chiu Wu, Chia-Hsuin ChangAssembly of study cohorts that evaluate the impact of antiviral treatment on the risks for infectious diseases morbidity and mortality in HCV and HBV patients.
History
Usage metrics
Read the peer-reviewed publication
Categories
Keywords
HBVUNLage 52.2 yearsinfection-related hospitalizationDAAbody mass indexHRBMIHCVALTreference grouphazard regression modelTaiwan National Health Insurance Research DatabaseNHIRDinfection-related deathshepatitis C virusCINBNCNC-HCVcohort study Background InfectionNC-HBVinfection riskC virus infection8.2- year follow-upNew Taipei City Health Screening
CC BY 4.0